Frontiers | Polo-Like Kinase 4's Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy
![PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1fab03d33f093b807e4c4dea23eab368e3b4ae0c/3-Figure1-1.png "PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar")
PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar
Polo-like Kinase (PLK) (Inhibitors Agonists Modulators Antagonists) | MedChemExpress
Frontiers | A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas
Understanding the Polo Kinase machine | Oncogene
Peptidomimetics Targeting the Polo-box Domain of Polo-like Kinase 1 | Journal of Emerging Investigators
Full article: Polo-like kinase 1 inhibitors in mono- and combination therapies: a new strategy for treating malignancies
Regulation of mitotic progression by Polo-like kinase 1 (PLK1). PLK1... | Download Scientific Diagram
Polo-like kinases: conservation and divergence in their functions and regulation | Nature Reviews Molecular Cell Biology
PLK1 - Wikipedia
Polo-like Kinase 1 Licenses CENP-A Deposition at Centromeres - ScienceDirect
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential | Journal of Medicinal Chemistry
Autoinhibition and relief mechanism for Polo-like kinase 4 | PNAS
Polo-Like Kinase - an overview | ScienceDirect Topics
Mitotic Roles of Polo Like Kinase
![PDF] The role of polo-like kinase 1 in carcinogenesis: cause or consequence? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/33119311272773173c201b3d02ff3ad18b4a1955/2-Figure1-1.png "PDF] The role of polo-like kinase 1 in carcinogenesis: cause or consequence? | Semantic Scholar")
PDF] The role of polo-like kinase 1 in carcinogenesis: cause or consequence? | Semantic Scholar
Polo-like kinase inhibitors in hematologic malignancies - ScienceDirect
Polo-like Kinase Inhibitor III | CAS 660868-91-7 | SCBT - Santa Cruz Biotechnology
Figure 2 from Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. | Semantic Scholar
A unified view of spatio-temporal control of mitotic entry: Polo kinase as the key | Open Biology
Pharmaceuticals | Free Full-Text | Inhibition of Polo-like Kinase 1 by HMN-214 Blocks Cell Cycle Progression and Inhibits Neuroblastoma Growth
Functions of Polo-Like Kinases: A Journey From Yeast To Humans | Bentham Science
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential | Journal of Medicinal Chemistry
